ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Women 80 And Older Benefit From Mammography

May 30, 2008

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement

March 17, 1995

Is the Concept of National Chain Of Outpatient Centers Still Viable?

May 2, 1997

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980